Dr. Nada Jabado, a pediatric hematologist-oncologist at Montreal Children’s Hospital, has just received the Outstanding Achievements in Cancer Research 2025 award from the Canadian Cancer Research Alliance.

A physician-scientist of the highest caliber, Dr. Nada Jabado’s scientific achievements have had international repercussions. His groundbreaking discovery of regulatory histone mutations as a fundamental hallmark of cancer and his paradigm-shifting finding that brain tumors arise from stalled development in embryonic neuronal hierarchies have transformed our understanding of pediatric and young adult brain tumors and opened new avenues for diagnosis and treatment.

Dr. Jabado is a senior scientist in the Child Health and Human Development Program at the Center for Translational Biology, McGill University Health Center Research Institute, and a professor in the Department of Pediatrics, Faculty of Medicine and Health Sciences, McGill University. She balances an ambitious research program with ongoing clinical service and remains committed to participating in national and international networks focused on the advancement of pediatric oncology.

“Lots of people talking together, working together, students coming and seeing an environment that encourages collaborative initiatives – that’s how we’re improving care,” he says.